Celldex Provides Corporate Update and Reports Full Year 2017 Results

Go back to Celldex Provides Corporate Update and Reports Full Year 2017 Results

Celldex (CLDX) Posts Smaller Q4 Loss

March 7, 2018 4:02 PM EST

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.03), $0.22 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $1.35 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

... More